Our investigation has revealed a positive correlation between elevated FDX1 expression in glioblastoma multiforme (GBM) patients, increased levels of tumor-associated macrophages, and reduced expression of CD4 + and CD8 + T cells, aligning with previous findings. The gene discussed is FDX1; the disease is neoplasm.